Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study

Table 3 Logistic regression analysis predicting the odds of entering the low-dose regimen

Predictor	Odds ratio	95% confidence interval	p value
Gender	0.809	0.504 to 2.405	0.809
Age	0.974	0.945 to 1.004	0.084
Disease duration (years)	1.011	0.978 to 1.046	0.511
RCDI	1.112	0.948 to 1.305	0.193
Seropositive (yes)	1.823	1.009 to 3.292	0.046
> 2 previous non-biologics	1.259	0.688 to 2.306	0.455
> 2 previous biologics (yes)	0.428	0.204 to 0.898	0.025
DAS28-ESR start	0.969	0.750 to 1.252	0.810
DAS28-ESR 6 months < 4.88 (yes)	2.329	1.254 to 4.325	0.007

ISSN: 1478-6362